Company & Sponsor Intelligence
Charite University, Berlin, Germany
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed0
Countries1
Therapeutic footprint
depression
Indexed studies
NCT02320994Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs
stroke · GermanyCOMPLETED
stroke · GermanyCOMPLETED
NCT00531726Berlin Deep Brain Stimulation Depression Study
depression · GermanyNA
depression · GermanyNA
NCT03094546Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline
alzheimers · GermanyPHASE2
alzheimers · GermanyPHASE2
NCT02439099Retinoic Acid Homeostasis in Neuropsychiatric Diseases
depression · GermanyUNKNOWN
depression · GermanyUNKNOWN
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →